ANZ Journal of Surgery is a distinguished academic journal published by Wiley, focusing on the evolving field of surgery within the broader context of medicine. With its roots established in 2001, this journal has steadily contributed to the academic community, earning a notable Q2 ranking in Surgery and a Q3 classification in miscellaneous Medicine as of 2023. Situated in the United Kingdom, the journal serves as a vital platform for both researchers and practitioners, fostering dialogue and disseminating high-quality research outputs. Although the journal currently does not offer an H-Index, its Scopus Rank places it in the 57th percentile among its peers, illustrating its relevance and impact on surgical research. The journal embraces a range of access options which can be explored further on its website, facilitating greater reach and engagement with its published content. As an essential resource for those in the field of surgery and related disciplines, the ANZ Journal of Surgery aims to advance surgical knowledge and practice, making significant contributions to patient care and outcomes.

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

The Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.

BMC Gastroenterology is a premier open-access journal published by BMC, dedicated to disseminating high-quality research in the field of gastroenterology. Established in 2001 and headquartered in the United Kingdom, this journal aims to enhance the understanding of gastrointestinal disorders through innovative research, reviews, and clinical studies. With an impressive impact factor and ranking within the Q2 category in gastroenterology and miscellaneous medicine for 2023, BMC Gastroenterology plays a critical role in advancing knowledge and practices in the field. The journal's commitment to open access ensures that researchers, professionals, and students worldwide can freely access and share vital findings and insights. Encouraging collaboration and knowledge transfer, BMC Gastroenterology is an essential resource for those dedicated to improving gastrointestinal health and outcomes.

Urologic Oncology - Seminars and Original Investigations is a premier journal published by Elsevier Science Inc, dedicated to advancing the field of urologic oncology through high-quality, peer-reviewed research and insightful scholarly discussions. With an ISSN of 1078-1439 and an E-ISSN of 1873-2496, this journal has established itself as a vital resource for professionals, researchers, and students alike since its inception in 1995. Currently holding a Q2 ranking in Oncology and a prestigious Q1 in Urology for 2023, it ranks 28th out of 120 in Urology and 177th out of 404 in Oncology within Scopus, underscoring its relevance and impact in these critical fields. While the journal operates under a subscription model, it continues to deliver compelling and transformative research aimed at enhancing patient outcomes in urologic oncology. With a focus on innovative therapies, diagnostic advancements, and clinical trials, the journal contributes significantly to ongoing dialogue and development in urologic health care.

The British Journal of Oral & Maxillofacial Surgery, published by Churchill Livingstone, is a leading international journal dedicated to the advancement of knowledge and practice in the field of oral and maxillofacial surgery. With a focus on disseminating high-quality research from 1984 to the present, this esteemed journal holds a significant position within the medical community, reflected in its impressive rankings in Scopus, including Q2 status in oral surgery, otorhinolaryngology, and general surgery. This journal is essential for researchers, practitioners, and students involved in related disciplines, providing them with valuable insights and updates on clinical practices, innovative techniques, and emerging trends in the field. While it currently does not offer open access options, its rigorous peer-review process ensures that only the most impactful articles contribute to the ongoing discourse in oral and maxillofacial surgery. With its base in the United States and a global readership, the British Journal of Oral & Maxillofacial Surgery continues to be a cornerstone for those aiming to elevate their personal expertise and the standard of care within their practices.

CURRENT PROBLEMS IN SURGERY is a premier journal dedicated to advancing the field of surgical practice through rigorous research and insightful reviews. Published by MOSBY-ELSEVIER, this esteemed journal boasts an impact factor that reflects its relevance, ranking in the Q2 category in both Medicine (miscellaneous) and Surgery as of 2023. With a comprehensive publication history from 1964 to 2024, it remains a vital resource for surgeons, researchers, and medical students alike. Although it does not offer open access, the journal provides a wealth of scholarly articles that are crucial for staying updated with the latest developments and challenges in surgery. The journal's Scopus rank of #76/551 in the Surgery category places it in the 86th percentile, further establishing its authority in the medical community. Based in the United States at 360 Park Avenue South, New York, NY 10010-1710, CURRENT PROBLEMS IN SURGERY fosters a dynamic platform for discourse, making it an indispensable companion for professionals navigating the complexities of modern surgical practices.

ANNALS OF VASCULAR SURGERY is a premier journal published by Elsevier Science Inc, focusing on the rapidly evolving field of vascular surgery and its related disciplines. With a notable impact factor reflected in its 2023 Q2 rankings in Cardiology and Cardiovascular Medicine, as well as in Medicine and Surgery, this journal stands out as a reputable source for cutting-edge research and clinical practices. Since its inception in 1986, it has aimed to advance knowledge, foster innovation, and enhance surgical techniques through comprehensive reviews, original research articles, and clinical trials. Although not currently adopting an open access model, the journal continues to serve as a crucial repository of information for researchers, clinicians, and students, facilitating the dissemination of clinical and scientific advancements in vascular health. As it converges through the years towards 2024, the ANNALS OF VASCULAR SURGERY is poised to remain a valuable resource for the global medical community.

The ANNALS OF SURGICAL ONCOLOGY, published by SPRINGER, stands as a leading journal dedicated to advancing the field of surgical oncology. With an ISSN of 1068-9265 and an E-ISSN of 1534-4681, this esteemed publication features high-quality research from 1994 to 2024, contributing significantly to the scientific dialogue surrounding surgical techniques, treatment innovations, and patient outcomes within the oncology community. The journal has earned a prestigious Q1 ranking in Surgery and a Q2 in Oncology for 2023, reflecting its pivotal role in influencing clinical practices and research in these fields. According to Scopus metrics, it ranks #51 out of 551 in Medicine Surgery and #133 out of 404 in Medicine Oncology, underscoring its academic rigor and impact. Despite being a subscription-based journal, the depth of knowledge disseminated through its pages is invaluable for researchers, professionals, and students aiming to stay at the forefront of surgical oncology advancements.

The European Journal of Surgical Oncology (EJSO), published by Elsevier Science Ltd, stands as a leading international journal dedicated to the field of surgical oncology. With an ISSN of 0748-7983 and an E-ISSN of 1532-2157, EJSO has been a key resource for researchers and practitioners since its inception in 1985, covering a wide spectrum of topics in advanced surgical techniques, oncology practices, and multidisciplinary approaches to cancer treatment. The journal boasts impressive rankings, being classified in the Q1 quartile for Medicine (Miscellaneous) and Surgery, and Q2 in Oncology for 2023, reflecting its high impact within the scientific community, with a Scopus ranking of #36/551 in Medicine and Surgery, placing it in the 93rd percentile. Although it does not currently offer Open Access options, EJSO remains committed to advancing the field through reliable research and innovative surgical methodologies. Its ongoing contributions are invaluable for those engaged in the continuous improvement of cancer treatment and management.